Cargando…
Targeting DNA damage response in cancer therapy
Cancer chemotherapy and radiotherapy are designed to kill cancer cells mostly by inducing DNA damage. DNA damage is normally recognized and repaired by the intrinsic DNA damage response machinery. If the damaged lesions are successfully repaired, the cells will survive. In order to specifically and...
Autores principales: | Hosoya, Noriko, Miyagawa, Kiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317796/ https://www.ncbi.nlm.nih.gov/pubmed/24484288 http://dx.doi.org/10.1111/cas.12366 |
Ejemplares similares
-
Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions
por: Hosoya, Noriko, et al.
Publicado: (2021) -
Synaptonemal complex proteins modulate the level of genome integrity in cancers
por: Hosoya, Noriko, et al.
Publicado: (2021) -
The Role of Mammalian STK38 in DNA Damage Response and Targeting for Radio-Sensitization
por: Fukasawa, Takemichi, et al.
Publicado: (2023) -
Somatic role of SYCE2: an insulator that dissociates HP1α from H3K9me3 and potentiates DNA repair
por: Hosoya, Noriko, et al.
Publicado: (2018) -
Targeting the DNA Damage Response for Cancer Therapy
por: Wang, Ruoxi, et al.
Publicado: (2023)